Peter Schuld

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemia.

From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemia.

Journal: Leukemia
Published: May 01, 2026

ASC4OPT: asciminib treatment optimization study in patients with chronic myeloid leukemia in chronic phase previously treated with two or more tyrosine kinase inhibitors.

ASC4OPT: asciminib treatment optimization study in patients with chronic myeloid leukemia in chronic phase previously treated with two or more tyrosine kinase inhibitors.

Journal: Leukemia
Published: March 20, 2026

Treatment-free remission after two nilotinib consolidation durations in chronic myeloid leukemia treated with imatinib: Phase 3 ENESTPath results.

Treatment-free remission after two nilotinib consolidation durations in chronic myeloid leukemia treated with imatinib: Phase 3 ENESTPath results.

Journal: Leukemia
Published: June 10, 2025

Improving chronic myeloid leukemia management and quality of life: patient and physician survey on unmet needs from the CML SUN survey.

Improving chronic myeloid leukemia management and quality of life: patient and physician survey on unmet needs from the CML SUN survey.

Journal: Haematologica
Published: March 07, 2025

Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry).

Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry).

Journal: Journal of cancer research and clinical oncology
Published: March 08, 2019

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study.

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study.

Journal: Leukemia
Published: July 09, 2015

Large-scale imatinib dose-concentration-effect study in CML patients under routine care conditions.

Large-scale imatinib dose-concentration-effect study in CML patients under routine care conditions.

Journal: Leukemia research
Published: October 03, 2013

Therapeutic drug monitoring of imatinib in chronic myeloid leukemia: experience from 1216 patients at a centralized laboratory.

Therapeutic drug monitoring of imatinib in chronic myeloid leukemia: experience from 1216 patients at a centralized laboratory.

Journal: Fundamental & clinical pharmacology
Published: May 30, 2012

High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III trial.

High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III trial.

Journal: Haematologica
Published: April 19, 2012
Showing 1-9 of 9

Last Updated: 09/26/2026